Supporting Efficient mAb Development with a Flexible Downstream Purification Toolkit

Bringing innovative antibody therapeutics to market quickly requires more than upstream efficiency. It demands adaptable and robust downstream purification strategies.

As novel mAb formats increase in complexity, purification challenges grow. Achieving required purity and yield often extends beyond traditional 2–3 step platform processes, requiring expanded chromatography options and optimized buffer systems.

In this webinar, we will discuss:

– Practical strategies for designing a flexible downstream purification toolkit
– Approaches to buffer optimization for challenging antibody molecules
– Ways to streamline process development while maintaining performance

Register to learn how a well-designed purification toolkit can help accelerate development timelines and improve process robustness.